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Figure 3. Comparison of ASM and proposed method.
Figure 4. Comparison of ASM and proposed method using VOE and VD.
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A302Conclusions: This study proposed a fully automated segmentation
algorithm based on ASM that combines the 3D shape context to obtain a
better knee cartilage extraction, and its performance was compared
with the original ASM. For 3D shape context, a block approach was
applied to adapt to bone shape construction. This consideration pro-
vides faster convergence, better matching and produces a better bone
mean shape which inﬂuences the results of bone segmentation. Proﬁle
based BCI extraction method is applied to extract BCI. By extracting
proﬁles and a threshold value which was obtained from experiments,
the proposed approach achieves to be more efﬁcient than those which
only consider neighbor intensity.
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IDENTIFICATION OF A NOVEL TARGET, FOXA2, IN THE ONSET AND
DEVELOPMENT OF OSTEOARTHRITIS
A.M. Ionescu y, L. Xu y, E. Kozhemyakina z, A. Lassar z, Y. Li y,
K. Kaestner x, M. Whitman y, V. Rosen y. yHSDM, Boston, MA, USA; zHMS,
Boston, MA, USA; xUPenn, Philadelphia, MA, USA
Purpose: The proposed studies are anticipated to establish whether
FoxA2 is a potential target for the treatment of OA, and also to provide
insights into mechanisms underlying OA initiation.
Methods: described in Results.Results: In OA, irreversible degradation of the “permanent” articular
cartilage by MMP13 is a key pathological event. Since I found that FoxA
factors control MMP13 expression in skeletal development, it seemed
possible they would to do the same in OA. Thus, we evaluated the
expression of FoxA2 in both healthy and OA cartilage using FoxA2IRES-
CreERT2/þ Tomato reporter mice. In healthy articular cartilage, the
majority of cells positive for FoxA2 expression (red) are located on the
tidemark (TM) or below, in the calciﬁed zone of the articular cartilage
(Fig.1). We also looked for co-localization of FoxA2 and MMP13 in
articular cartilage by performing immunoﬂuorescence for MMP13 on
sections from FoxA2IRES-CreERT2/þ;Tomato mice and found that
FoxA2 positive cells (red) and MMP13 positive cells (green) overlap in
the hypertrophic zone (overlay yellow) (Fig.1).
Next, we looked at expression of FoxA2 in OA articular cartilage using
the Destabilization of the Medial Meniscus (DMM)murine model of OA.
We performed DMM surgery on FoxA2IRES-CreERT2/þ; Rosa26LacZ
reporter mice, injected the mice with tamoxifen, and stained the knee
joints for beta-galactosidase activity. We found that the number of LacZ
FoxA2-positive cells located ABOVE the tidemark in the operated knee
articular cartilage is 3.4-fold higher than the number of FoxA2-positive
cells observed above the tidemark in the control knee (Fig.2). This
suggests that induced expression of FoxA2 above the tidemark corre-
lates with the localization of induced MMP13 expression in this murine
model of OA.
Since FoxA2 expression is induced in murine OA cartilage, we next
asked whether FoxA2 is necessary for cartilage degradation, and
examined whether the loss of FoxA2 in superﬁcial articular cartilage
would alter the progression of the disease in the DMM surgical model.
To delete FoxA2 speciﬁcally in the chondrocyte population above the
tidemark, we employed a mouse line that contains a tamoxifen-indu-
cible CRE recombinase (CreERT2) driven by the Prg4 (Lubricin) regu-
latory sequences. Tamoxifen treatment of Prg4GFPCreERt2/þ;
Rosa26LacZ mice induces recombination at the Rosa26lacZ locus and
labels the cells in the top 3 cell layers of the articular cartilage (Fig.3A).
Using this line, we speciﬁcally removed FoxA2 from the superﬁcial cells
of articular cartilage by injecting 6-week old Prg4CreERt2-GFP;FoxA2ﬂ/
ﬂ mice with either tamoxifen or corn oil followed by DMM or sham
surgery. At 16 weeks post surgery, knee joints were processed for
Safranin O/Fast green staining and scored for cartilage degradation
using the OARSI histological scale. While control (corn oil treated)
Prg4þ/CreERt2-GFP; FoxA2ﬂ/ﬂ mice (with intact FoxA2) displayed
signiﬁcant cartilage destruction following DMM surgery (OARSI score of
3.2), tamoxifen treated Prg4þ/CreERt2-GFP; FoxA2ﬂ/ﬂ; mice had con-
siderably less (42%) cartilage destruction (OARSI score of 1.9) (Fig.3B).
These ﬁndings demonstrate that loss of FoxA2 in articular cartilage can
slow the progression of cartilage destruction following surgically
induced joint destabilization.
I next asked whether overexpression of FoxA2 in murine articular car-
tilage cells is sufﬁcient to accelerate cartilage degradation. To drive
exogenous FoxA2 expression in articular chondrocytes, I have generated
mice containing the FoxA2 transgene driven by a reiterated reverse
tetracycline transactivator (rtTA) response element (TREtight-FoxA2). I
performed surgical destabilization of the medial meniscus on either the
triple transgenic Prg4CRE;rtTA;TgFoxA2 mice or their control
Prg4CRE;rtTA littermates both treated with Doxycycline. Control mice,
lacking the FoxA2 transgene, that have undergone surgery developed
mild symptoms of the disease (OARSI score 1.37±0.33). In contrast,
triple transgenic mice that have undergone surgery developed far more
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A303cartilage damage with more lesions on the articular cartilage (OARSI
score 2.63±0.43).
Conclusions: We have found that conditional deletion of FoxA2 in a
murine model of osteoarthritis prevents disease progression, while
overexpression of FoxA2 accelerates progression of the disease. Taken
together these preliminary results suggest that inhibiting FoxA factors
could represent a potential therapeutic intervention to ameliorate the
progression of OA.
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CHARACTERIZATION OF RAT OSTEOARTHRITIS MODEL:
CORRELATION BETWEEN WEIGHT BEARING, SERUM BIOMARKERS,
IMAGING AND HISTOLOGY
C.M. Bagi. Pﬁzer, Inc, Groton, CT, USA
Purpose: The objectives of this work were to assess the pathophysiol-
ogy of articular cartilage and subchondral bone in the rat medial
meniscal tear model (MMT) of osteoarthritis and to evaluate the
application of various endpoints and assessment techniques. Standard
methods, including histology and serum biomarkers were compared
and contrasted with weight bearing and microCT assessment to deter-
mine the diagnostic and prognostic value of such endpoints for in
studies designed to evaluate efﬁcacy and safety of anti-arthritis
medicines.
Methods: MMT surgery was performed on male Lewis rats were to
induce OA. Biomarkers of bone and cartilage metabolism (Osteocalcin,
P1NP, CTX I, TRAP5b, CTX-II) were evaluated in the serum. A Dynamic
Weight Bearing (DWB) system was utilized to measure functional
capacity of the musculoskeletal system and 3-point bending method
was used to assess femur strength. Micro-CT (mCT) and contrast (EPIC)
mCT were used to evaluate bone geometry and articular cartilage
morphology. Fluorescent labels (calcein and alizarin red-S) were used to
assess bone remodeling by histomorphometry in undemineralized
bone sections. Articular cartilage and bone morphology was evaluated
using histology (H&E, Toluene blue, Safranin-O, Cathepsin -K).
Results: DWB data showed distinctive difference in weight bearing
capacity between control and OA rats and provided the substrate for
bone loss evidenced by micro-CT in the tibia of an operated hind limb.
Contrast enhanced 3D mCT data clearly demonstrated degradation of
articular cartilage covering the medial tibial plateau in MMT rats, and
these data correlated extremely well with cartilage histology by tradi-
tional parafﬁn histology. Dynamic bone histomorphometry showed
increased subchondral bone formation beneath the damaged cartilage
in the tibias of MMT rats, as well as, active osteophyte formation at the
medial aspect of the tibial plateau. Serum biomarkers of bone and
cartilage metabolism correlated well with mCT and histology.
Conclusions: DWB data indicate that the joint damage is partially
dependent upon weight bearing capacity of injured limb, while mCT
data and dynamic histomorphometry clearly demonstrate that different
bone compartments within the same limb react differently to MMT
surgery; bone loss at tibial metaphysis and bone formation of the
subchondral bone at tibial epiphysis. Contrast enhanced EPIC-mCT
imaging provides a reproducible method to assess 3D distribution of
GAGs in the articular cartilage of laboratory rats. Contrast imaging data
are complementary to histological ﬁndings and can be utilized to guide
histological assessment. Serum biomarkers along with imaging have
abundant translational value when preclinical data are extrapolated to
the clinical milieu.
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MEDIAL CARTILAGE LESIONS DETECTED BY 3.0-TESLA MRI ARE THE
RISK FACTOR FOR THE PROGRESSION OF EARLY-STAGE MEDIAL
KNEE OSTEOARTHRITIS
R. Sadatsuki y, H. Kaneko y, L. Liu z, S. Hada y, M. Kinoshita y, A. Yusup y,
Y. Kobayashi y, Y. Saita y, Y. Takazawa y, K. Kaneko y,z, M. Ishijima y,z.
yDept. of Med. for Orhtopaedics and Motor Organ, Juntendo Univ.
Graduate Sch. of Med., Tokyo, Japan; z Sportology Ctr., Juntendo Univ.
Graduate Sch. of Med., Tokyo, Japan
Purpose: It is currently impossible to prevent the progression of the
knee osteoarthritis (OA). OA has been believed that cartilage is the
primary and most important source of lesions that lead to the disease.
However, in addition to cartilage, the importance of all parts of the joint,
including the bone, meniscus, ligaments, muscle, and synovium and thecrucial role of inﬂammation in these parts that were previously con-
sidered to be irrelevant in this condition are now recognized to be
important for OA. The symptoms, especially pain, are also known to be
one of the risk factor for the progression of OA. It is impossible to detect
the OA-related early changes of the cartilage using radiograph. A
magnetic resonance imaging (MRI) is currently underway to facilitate
the understanding the pathophysiology of the early stage of knee OA, as
it can detect not only bone but also other structural changes occurred in
OA. In this study, we examined the factors in patients with early-stage
knee OA among the radiographic- and MRI-detected structural changes
of the knee joint and the clinical symptoms which were associated with
the radiographic OA progression after three years of follow up.
Methods: Among the one-hundred thirty-two early stage medial knee
OA patients with K/L grade 1 or 2 who visited our hospital from January
2009 to December 2011 for medial knee pain, thirty-ﬁve patients who
were able to follow up for three years were registered. At baseline, the
knee radiographs, JKOM score, a patient-oriented outcome measure,
and 3.0-Tesla knee MRI were performed. The progression of knee OA
was evaluated by radiographs taken at three years from the baseline.
OA-related structural changes in the knee joint evaluated by MRI were
semi-quantiﬁed using the Whole-Organ Magnetic Resonance Imaging
Score (WORMS). The subjects were divided into two groups by the
presence or absence of the progression of the disease (P; progress
group, n¼22; NP; non-progression group, n¼13). When the K/L grade of
the patients were progressed one or more grades after 3 years, they
were deﬁned as P. Difference between the two groups was determined
by Mann-Whitney U test, and logistic regression analysis was per-
formed using SPSS ver.19.0.
Results: No signiﬁcant differences of the medial knee joint space width
(JSW) and femoro-tibial angle (FTA) by radiographs at baseline were
observed between NP and P (p¼0.73 and 0.31, respectively). Among the
MRI-detected joint changes induced by knee OA and evaluated by
WORMS, the medial cartilage lesion score in P (4.70) was only sig-
niﬁcantly increased in comparison to that in NP group (1.62) at baseline
(p¼0.01). At three years after follow up, the JSWs of the patients in P
were signiﬁcantly decreased in comparison to those of the patients in
NP (p¼0.007). The MRI-detected medial cartilage lesions showed the
signiﬁcant negative association with the radiographic medial knee joint
space width (JSW) after three years of follow up (r¼-0.382, p¼0.02). The
logistic regression analysis adjusted for age and BMI revealed that
among the radiographic OA-related parameters, such as JSW and FTA,
pain VAS, JKOM score and the MRI-detected eight parameters, the
medial cartilage lesion was only associated with the knee OA pro-
gression (OR; 5.02, 95%CI: 1.05 to 23.96, p¼0.043).
Conclusions: When the structural changes of knee OA were precisely
evaluated by 3TMRI andWORMS, the cartilage damage was found to be
the most important factor for the progression of the early-stage knee
OA.
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BONE MARROW LESIONS DETECTED BY DIFFERENT MAGNETIC
RESONANCE SEQUENCES AS POTENTIAL BIOMARKERS FOR KNEE
OSTEOARTHRITIS: COMPREHENSIVE TISSUE LEVEL ANALYSIS
D. Muratovic y,z, F.M. Cicuttini x, A.E. Wluka x, Y. Wang x, D.M. Findlay z,
S. Otto k, D.J. Taylor ¶, S. Collings ¶, J.M. Humphries y, Y.R. Lee y,
G. Mercer#, J.S. Kuliwaba y,z. yBone and Joint Res. Lab., SA Pathology,
Adelaide, Australia; zDiscipline of Orthopaedics and Trauma, The Univ.
of Adelaide, Adelaide, Australia; xDept. of Epidemiology & Preventive
Med., Monash Univ., Melbourne, Australia; kAnatomical Pathology, SA
Pathology, Adelaide, Australia; ¶Dept. of Radiology, Royal Adelaide Hosp.,
Adelaide, Australia; #Dept. of Orthopaedics, Repatriation Gen. Hosp.,
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Purpose: Osteoarthritis (OA) is well recognised as a multifactorial dis-
ease of the whole joint with signiﬁcant involvement of the subchondral
bone. Epidemiological studies have demonstrated a strong association
between MRI-detected bone marrow lesions (BMLs) and the severity of
symptoms and structural degeneration in knee OA. Thus, BMLs appear
to have diagnostic and prognostic value, and potentially represent a
therapeutic target for knee OA. What BMLs represent at the cartilage-
subchondral bone tissue level is poorly described and it is not known
whether different MRI sequences detect the same tissue characteristics.
Therefore, the aim of this study was to characterise the cartilage-sub-
chondral bone morphometric features corresponding to BMLs detected
using two different MRI sequences for a cohort of knee OA individuals.
